Transdermal fentanyl is a well-used and highly effective form of opioid analgesia for patients suffering with severe chronic pain. It is also an opioid that is widely abused. Acute clinicians need to be aware of the methods by which fentanyl patches may be used both therapeutically and illicitly as well as the impact this can have in managing a patient’s period of intoxication.

[download-attachments container="div" style="list" display_icon="1" display_count="1" display__size="0"]

References

1. Els C, Jackson TD, Hagtvedt R, et al High‐dose opioids for chronic non‐cancer pain: an overview of Cochrane Reviews. Cochrane Database of Systematic Reviews 2017, Issue 10. Art. No.:CD012299
2. TH Stanley J Pain Symptom Management 1992;7(3 Suppl):S3-7
3. CK Phua, A Wee, A Lim et al Fentanyl-induced chest wall rigidity syndrome in a routine bronchoscopy. Resp Med Case Rep. 2017;20: 205–20
4. Horton R, Barber C. Opioid-Induced Respiratory Depression Resulting from Transdermal Fentanyl-Clarithromycin Drug Interaction in a Patient with Advanced COPD. J Pain and Symptom Manage, 2009; 37(6),e2 - e5
5. Durogesic DTrans 12mcg/hr transdermal patch https://www.medicines.org.uk/emc/product/157/smpc (accessed 4/6/2020)
6. MHRA Drug Safety Update March 2018 https://www.gov.uk/drug-safety-update/benzodiazepines-and-opioids-reminder-ofrisk-of-potentially-fatal-respiratory-depression
7. A.S. Michaels, S.K. Chandrasekaran, J.E. Shaw. Drug permeation through human skin: theory and in vitro experimental measurement AIChE J 1975; 21(5): 985-996
8. Lane ME, The transdermal delivery of fentanyl. European Journal of Pharmaceutics and Biopharmaceutics 2013;83: 449-455
9. Kornick CA, Santiago-Palma J, Moryl N et al. Benefit-Risk Assessment of Transdermal Fentanyl for the Treatment of Chronic Pain A.M.T. Obbens Drug Safety 2003; 26 (13): 951-973
10. J.R. Varvel, S.L. Shafer, S.S. Hwang, et al. Absorption characteristics of transdermally administered fentanyl, Anaesthesiology 1989:70:928–934
11. Kuip EJM, Zandvliet ML, Koolen SL et al A review of factors explaining variability in fentanyl pharmacokinetics; focus onimplications for cancer patients. Br J Clin Pharmacol (2017) 83 294–313
12. Paparella SF. A serious threat to patient safety: the unintended misuse of fentanyl patches J Emerg Nurs 2013;39:245-7
13. Borg R, Ashton A. A case of overdose via tattoo. Journal of the Intensive Care Society 2015;16(3): 253–256)
14. Sindali K, Sherry K, Sen S et al Life-threatening coma and fullthickness sunburn in a patient treated with transdermal fentanyl patches: a case report. J Med Case Rep 2012;6:220
15. Greenall J, Koczmara C, Cheng R et al. Safety Issues with Fentanyl Patches Require Pharmaceutical Care C J H P – Vol. 61, No. 1 – January–February 2008
16. Mansfield A. Mansfield A.S. Jatoi A. Asphyxiation with a Fentanyl Patch Case Rep Oncol 2013;6:242-244
17. Nara A. Yamada C, Saka B.S. et al J Forensic Sci, November 2019 Vol. 64, No. 6 1936-1942